Fibroid Clinical Trial
Official title:
3 Dimensional Ultrasound in Comparison to Hysteroscopy in Diagnosis of Myomas
NCT number | NCT04736095 |
Other study ID # | 3D |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | February 7, 2021 |
Est. completion date | May 17, 2021 |
Verified date | May 2021 |
Source | Aljazeera Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
• three-dimensional saline infusion sonohysterography (3D SIS) was performed in all cases. A sterile Cuscoe speculum was passed, the cervix visualized and cleaned with sterile chlorhexidine solution. A 3.3 mm soft plastic paediatric naso-gastric suction catheter was then passed through the cervix into the uterine cavity without grasping the cervix.
Status | Completed |
Enrollment | 50 |
Est. completion date | May 17, 2021 |
Est. primary completion date | May 15, 2021 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 20 Years to 60 Years |
Eligibility | Inclusion Criteria: - • Women between 20 and 60 years with abnormal uterine bleeding in form of heavy menstrual bleeding, irregular and heavy menstrual bleeding) diagnosed on non-enhanced two-dimensional ultrasonography with submucous fibroids. - Absence of STD, PID, active vaginal bleeding. Exclusion Criteria: - Presence of general cause of abnormal uterine bleeding - History of drug use that can cause vaginal bleeding (anticoagulants, OCPs, HRT) - History of recent hormonal treatment - High risk of undergoing hysteroscopy - Vaginal, Vulval causes of bleeding |
Country | Name | City | State |
---|---|---|---|
Egypt | Algazeerah | Giza | |
Egypt | Aljazeera( Al Gazeera) hospital | Giza |
Lead Sponsor | Collaborator |
---|---|
Aljazeera Hospital | Cairo University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The accuracy of 3D ultrasound in doiagnosis of submucous myomas in comparison to hysteroscopy | How many women will be diagnosed by 3D US to have submucous myoma | one week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00891657 -
Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy
|
N/A | |
Active, not recruiting |
NCT03323905 -
Single Arm Study Using the Symphony -- MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas
|
N/A | |
Recruiting |
NCT06135870 -
Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
|
||
Recruiting |
NCT03143114 -
Effect of Myomectomy for Intramural Myoma on Fertility Outcomes in Infertile Women
|
N/A | |
Not yet recruiting |
NCT06392997 -
Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology
|
||
Recruiting |
NCT06143631 -
Prescription of Letrozole for Uterine Myoma
|
Phase 4 | |
Recruiting |
NCT03784976 -
Iyengar Yoga Therapy for Dysmenorrhea and Endometriosis
|
N/A | |
Completed |
NCT02166411 -
Laparoscopic Myomectomy Using Barbed or Conventional Sutures
|
Phase 2 | |
Recruiting |
NCT02361879 -
Ulipristal Acetate Versus GnRH Analogue Treatment Before Hysteroscopic Resection of Uterine Leiomyoma
|
Phase 4 | |
Recruiting |
NCT02361905 -
Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas
|
Phase 4 | |
Recruiting |
NCT02357563 -
Ulipristal Acetate Versus GnRH Analogue and Myometrial Preservation
|
Phase 4 | |
Completed |
NCT00427544 -
Study of the Safety, Tolerability, and PK of PRA-027 Administered to Women of Nonchildbearing Potential
|
Phase 1 | |
Enrolling by invitation |
NCT03937401 -
Oxytocin in MRI-HIFU
|
Phase 4 | |
Completed |
NCT00746031 -
Novel MRI Strategies as a Non-invasive Biomarker in Women With Uterine Fibroids
|
Phase 4 | |
Recruiting |
NCT00323999 -
Hysteroscopic Monopolar and Bipolar Resection
|
N/A | |
Terminated |
NCT02825719 -
Ulipristal Use in Chinese Population
|
Phase 4 | |
Not yet recruiting |
NCT03122782 -
Hemostatic Effect of Intrauterine Instillation Of Tranexamic Acid In Hysteroscopic Myomectomy
|
Phase 3 |